2004
DOI: 10.1016/j.bmcl.2004.02.098
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of series of isobenzofuranone dimers as PKCα ligands: implication for the distance between the two ligand binding sites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…Baba et al designed new isobenzofuranone template for PKC ligands retaining the same binding motifs as DAG (Fig. 4) [41,42]. The presence of a benzene ring delivered considerable scope for modification and was regarded as an asset in the development of isozyme-selective analogs.…”
Section: Design Of Bivalent Ligandsmentioning
confidence: 98%
“…Baba et al designed new isobenzofuranone template for PKC ligands retaining the same binding motifs as DAG (Fig. 4) [41,42]. The presence of a benzene ring delivered considerable scope for modification and was regarded as an asset in the development of isozyme-selective analogs.…”
Section: Design Of Bivalent Ligandsmentioning
confidence: 98%
“…To date, several bivalent PKC ligands based on naphthylpyrrolidone, phorbol ester, , and isobenzofuranone have been synthesized and evaluated for their PKC binding and membrane interaction. In no case has there been substantial capture of enhanced affinity suggestive of the simultaneous binding to both C1 domains.…”
Section: Introductionmentioning
confidence: 99%
“…These responses regulate numerous cellular processes, , including proliferation, differentiation, migration, and apoptosis. , Membrane translocation of PKC is caused by binding of ligands to the C1b domain and has been recognized as an important phenomenon in signal transduction because the localization of PKC is key in determining isozyme-specific functions by defining binding partners for downstream signaling . Despite the complex regulatory mechanisms of PKC activation, considerable progress has been made in understanding isozyme-specific functions and several ligands with high specificity for PKC isozymes have been developed as potential drugs. Through the development of DAG-lactones, whose design is based on the endogenous ligand DAG, the importance of maintaining intact the pharmacophore triad of two carbonyl groups ( sn -1 and sn -2) and the primary alcohol has been established as a requirement in high affinity ligands for PKC (Figure ) . Various PKC ligands have been synthesized and found to be inhibitors of tumor promotion or of other diseases.…”
Section: Introductionmentioning
confidence: 99%